This course has expired. View available courses.
Neurology
DMT Safety Update: A Review of Safety Profiles and Monitoring Requirements
The number of disease modifying therapies (DMTs) available to treat multiple sclerosis (MS) has expanded greatly over the last ten years. Although some of the newer DMTs are associated with better control compared to older injectable therapy, they are also associated with more complex safety profiles and specific monitoring requirements.
This program reviews the safety profiles of DMTs and summarizes their monitoring requirements, with the goal of supporting clinicians in optimizing the safety of MS therapy.
This program has received an unrestricted educational grant or in-kind support from Roche.
DURATION
30 min
PROFESSION
Physician, Nursing, Pharmacy, Medical Resident, Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 1, SCFHS
EXPIRY DATE
2023-03-09
The number of disease modifying therapies (DMTs) available to treat multiple sclerosis (MS) has expanded greatly over the last ten years. Although some of the newer DMTs are associated with better control compared to older injectable therapy, they are also associated with more complex safety profiles and specific monitoring requirements.
This program reviews the safety profiles of DMTs and summarizes their monitoring requirements, with the goal of supporting clinicians in optimizing the safety of MS therapy.
This program has received an unrestricted educational grant or in-kind support from Roche.
Faculty
Hind Alnajashi, MD
Amani A Alshehri, PharmD
Learning objectives
Upon viewing the educational video and completing requirements, participants will be better able to:
- Communicate potential adverse effects to patients who are starting treatment with a DMT.
- Discuss the monitoring protocols for DMTs.
- Advise patients on how to manage certain adverse effects and when to follow up with their clinician.
Accreditation
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.